☆ 4.0 Meeting Abstract

MIPOMERSEN, AN APOB SYNTHESIS INHIBITOR, EVALUATION OF POTENTIAL TO REDUCE NECESSITY FOR LIPID-APHERESIS IN PATIENTS WITH HETEROZYGOUS FH AND CAD

ATHEROSCLEROSIS SUPPLEMENTS (2011)

Journal

ATHEROSCLEROSIS SUPPLEMENTS

Volume 12, Issue 1, Pages 159-159

Publisher

ELSEVIER IRELAND LTD

DOI: 10.1016/S1567-5688(11)70761-9

Keywords

-

Categories

Peripheral Vascular Disease

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.